Cardium To Intoduce MedPodium Product Line

Cardium Therapeutics (Cardium) has planned to launch a new premium advanced skin care product line to promote foot health and comfort for podiatry patients. Cardium’s new MedPodium product line is an over-the-counter product portfolio for patients with the potential for foot disorders and ailments.

MedPodium represents a new line of foot care products to broaden and complement Cardium’s Excellagen topical gel product candidate platform, which is currently subject to a pending FDA 510(k) application submission for US marketing clearance, for the management of wounds including partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, surgical wounds and certain other wounds.

The MedPodium patient care podiatric product line, which will initially carry six products, has been designed to promote foot health and comfort and support preventative care, self examination and early detection of foot ulcers, especially for diabetic patients with lower extremity neuropathy.

The MedPodium product line has been formulated to include blended natural and botanical ingredients, and will have no artificial colors and fragrances. Daily use of MedPodium’s natural cremes and gels are intended to assist self examination and early detection of foot ulcers, which can potentially become a serious and chronic medical problem that can contribute to increased morbidity and mortality, without proper care and early treatment, especially for diabetic patients.

The commercial development of Cardium’s MedPodium patient care product line is intended to provide a first line of defense for individuals at risk for foot ulcers and enhances and expands Cardium’s product portfolio beyond the current Excellagen product candidate platform.

In early December, Cardium has filed a 510(k) application for US marketing clearance for the Excellagen product candidate. The ExcellagenFX flowable matrix product candidate is designed to allow for deeper administration and direct intimate contact with the wound bed in these more complex, irregular and difficult to access wounds

Christopher Reinhard, chairman and CEO of Cardium, said: “Our new MedPodium product line seeks to provide patients with ways to support prevention, self examination and early detection, and provide comfort and promote soft and supple skin, consistent with industry guidelines for good foot health.

“We look forward to the commercial launch of our initial six MedPodium patient care products and, subject to FDA marketing clearance, our Excellagen product candidate platform that will also include two professional care products for use by podiatrists and other professional health care providers.”